Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > International Molecular Screening Program for… >

International Molecular Screening Program for Metastatic Breast Cancer AURORA at IMPAKT

Published: May 7, 2014.
Released by Breast International Group (BIG)-aisbl  

While research has made great strides in recent decades to improve and significantly extend the lives of patients with early breast cancer, the needs of patients with advanced or metastatic disease have largely been ignored. Moreover, despite the fact that the overall breast cancer death rate has dropped steadily over the last decade and significant improvements in survival have been made, metastatic breast cancer represents the leading cause of death among patients with the disease.

In this context the Breast International Group (BIG) recently launched AURORA, which will use molecular screening to improve our understanding of metastatic breast cancer and its response or lack of response to available drug therapies. In total 1300 women and men from about 60 hospitals in 15 European countries are expected to take part in the programme. Over time, BIG hopes to expand the programme well beyond Europe to involve several 1000 more patients.

Dr Martine Piccart-Gebhart, Chair of BIG and Director of the Medicine Department of the Institut Jules Bordet, strongly believes in this research programme and says: "It is almost unethical that we continue to treat women with metastatic breast cancer when we have so little knowledge of their disease. We now have powerful technologies for investigating the molecular landscape of tumours, and we have an obligation to women to establish AURORA as a large translational research effort that can hopefully lead to more effective treatments in the future".

Within AURORA, metastatic and primary breast cancer tissue specimens will be collected and screened with a panel of more than 400 cancer-related genes for the first time on a large scale. Plasma and blood samples will also be collected, and any samples not analysed immediately will be stored in an independent bio-repository to enable future research. An innovative bioinformatics platform has been developed to support the collection of AURORA data. These data are being collected in a way that will allow sharing and collaborating in the context of other initiatives started by researchers in North America.

AURORA will enable scientists to understand both why breast cancer metastasises and why some patients respond poorly to standard treatment, while others respond very well. Whenever possible, patients participating in AURORA will be offered to participate in a clinical trial testing new and promising drugs that target the specific genetic characteristics of their tumours. The ultimate hope is that AURORA will benefit patients by leading us to both better treatments and to finding cures for the women and men affected by this disease.

The above story is based on materials provided by Breast International Group (BIG)-aisbl.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish

comments powered by Disqus

Related »

Silencing a Deadly Conversation in Breast Cancer
While it is already known that breast cancer cells create the conditions for their own survival by communicating their …
Experts Issue Plea for Better Research And Education for Advanced Breast Cancer
Breast cancer experts around the world have issued a plea to researchers, academics, drug companies, funders and advocates to …
Another Step Toward Resisting Breast Cancer
Medical researchers at the University of Leeds have come a step closer to understanding how to stop breast cancers …
Discovery Has Potential to Boost Tamoxifen's Effectiveness
SCIENTISTS in London have found a potential new way of boosting the effectiveness of the anti-breast cancer drug, tamoxifen. …
Scientists Identify Key to Preventing Secondary Cancers
Leading scientists from the University of Sheffield and University of Copenhagen have identified a possible key to preventing secondary …
Australian Scientists' Work Could Influence Breast Cancer Treatment
WORK by scientists in Australia could open the door to a new way of treating certain breast cancers. …
Breast Cancer Study Raises Hope of Therapy to Stop Tumor Spread
Scientists have discovered a trigger that allows breast cancer cells to spread to the lungs. They have found …
Study Opens New Prospects for Developing New Targeted Therapies for Breast Cancer
Lugano-CH, Brussels-BE, 2 May 2013 -- A study led by prominent breast cancer experts from Europe and the US …
Everolimus Plus Exemestane Improves Bone Health in Post-menopausal Women with Advanced Breast Cancer
Vienna, Austria: Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women …
Alternative Target for Breast Cancer Drugs
HEIDELBERG, 19 July 2013 – Scientists have identified higher levels of a receptor protein found on the surface of …
Gene 'Switches' Could Predict When Breast Cancers Will Spread to the Brain
SCIENTISTS have found a pattern of genetic 'switches' – chemical marks that turn genes on or off - that …

UAlberta Researchers Stop 'Vicious Cycle of Inflammation' That Leads to Tumor Growth

New Anti-cancer Compound Shows Promise for Breast Cancer
Vall D’Hebron, VHIO And SOLTI Head Up an International 'Dream Team' Against Breast Cancer
Barcelona, 19 September 2012. The Vall d'Hebron Breast Cancer Unit, the Vall d'Hebron Institute of Oncology (VHIO) and SOLTI, …
More » 
© Newsline Foundation  |  About  |  Privacy Policy  |  Feedback  |  Mobile